| |
Total (n = 346)
|
DOAC (n = 74)
|
Vitamin K antagonist (n = 272)
|
p
|
|---|
|
PCC (units), [median (IQR)]
|
2100
|
(1800-2400)
|
2000
|
(1700–3000)
|
2100
|
(1800-2400)
|
0.346
|
|
ECs given
|
48
|
(13.9)
|
15
|
(20.3)
|
33
|
(12.1)
|
0.073
|
|
Number of ECs
|
|
1
|
23
|
(6.7)
|
6
|
(8.2)
|
17
|
(6.2)
| |
|
2
|
14
|
(4.1)
|
3
|
(4.1)
|
11
|
(4.0)
| |
|
3
|
7
|
(2.0)
|
4
|
(5.5)
|
3
|
(1.1)
| |
|
4
|
2
|
(0.6)
|
2
|
(2.7)
|
0
|
(0.0)
| |
|
5
|
2
|
(0.6)
|
0
|
(0.0)
|
2
|
(0.7)
|
0.014
|
|
Platelet concentrates
|
5
|
(1.4)
|
2
|
(2.7)
|
3
|
(1.1)
|
0.307
|
|
Fresh frozen plasma
|
19
|
(5.5)
|
6
|
(8.1)
|
13
|
(4.8)
|
0.265
|
|
Tranexamic acid
|
41
|
(11.8)
|
21
|
(28.4)
|
20
|
(7.4)
|
< 0.001
|
- Abbreviation: DOAC direct oral anticoagulants, ECs erythrocyte concentrates, IQR interquartile range, PCC prothrombin complex concentrate
